+49 152 22 82 97 73
 

Services

Germany

  • Situation analysis for medical devices, e-Health and pharmaceuticals
  • Execution of advisory boards and interview projects in order to optimize the strategy
  • Guidance for the development of the global clinical development program (incl. study design, endpoints, etc.) from a German payer’s perspective
  • Consultation of the German joint federal committee (G-BA)
  • Guidance for the optimized payer positioning of clinical study results
  • Development and submission of GBA dossiers according to §35a SGB V
  • Support in the written response with respect to IQWIG benefit assessments / recommendations
  • Development and adaptation of health economic models and cost-efficiency frontiers
  • NUB, OPS, DRG, EBM, GOÄ applications for medical devices
  • Analysis of German health insurance data (GKV Routinedaten)
  • Support in integrated care concepts for new medical devices
  • Support in direct / selective contracting with German health insurances (incl. pilot studies)
  • Local decision maker support (MVZ, selective contracts for mayors and local health organizations) - more information on www.mars-gesundheitspolitik.de 

Austria

  • Situation analysis for medical devices and pharmaceuticals
  • Execution of advisory boards and interview projects in order to optimize the strategy
  • Guidance for the development of the global clinical development program (incl. study design, endpoints, etc.) from an Austrian's payer’s perspective
  • Guidance for the correct payer positioning of clinical study analyses results (e.g. subgroups, clinical endpoints, appropriate comparator)
  • Development and submission of reimbursement dossiers to the Hauptverband
  • Development and adaptation of health economic models
  • Reimbursement support and application for medical devices

Switzerland

  • Situation analysis for medical devices and pharmaceuticals
  • Execution of advisory boards and interview projects in order to optimize the strategy
  • Guidance for the development of the global clinical development program (incl. study design, endpoints, etc.) from a Swiss payer’s perspective
  • Consultation of Swissmedic and BAG
  • Guidance for the correct payer positioning of clinical study analyses results (e.g. subgroups, clinical endpoints, appropriate comparator)
  • Development and submission of BAG dossiers
  • Negotiation simulations
  • Development and adaptation of health economic models
  • Reimbursement applications for medical devices

Global Services & Applied methodologies

  • Market access & pricing strategy development:
    • Development of optimal price and reimbursement strategies in the various lifecycle stages of a compound
    • Early Pricing Guidance
    • Strategic Payer Plan
    • Execution of advisory boards and interview projects in order to optimize the strategy
    • Guidance for the development of the global clinical development program (incl. study design, endpoints, etc.) from a payer’s perspective
    • Development of health economic models
  • Execution of Network Meta-Analysis / Mixed Treatment Comparisons
    • Execution of Systematic Literature Searches
    • Execution of (network) meta-analyses and indirect treatment comparisons
  • Willingness-to-pay and preference measurements applying conjoint analysis
  • Dissemination of scientific findings in more than 100 scientific publications